List of Excipients in API tapentadol hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tapentadol hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Stat Rx USA | NUCYNTA | tapentadol hydrochloride | 16590-863 | ALUMINUM OXIDE | 2026-07-03 |
| Stat Rx USA | NUCYNTA | tapentadol hydrochloride | 16590-863 | CELLULOSE, MICROCRYSTALLINE | 2026-07-03 |
| Stat Rx USA | NUCYNTA | tapentadol hydrochloride | 16590-863 | CROSCARMELLOSE SODIUM | 2026-07-03 |
| Stat Rx USA | NUCYNTA | tapentadol hydrochloride | 16590-863 | LACTOSE MONOHYDRATE | 2026-07-03 |
| Stat Rx USA | NUCYNTA | tapentadol hydrochloride | 16590-863 | MAGNESIUM STEARATE | 2026-07-03 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for tapentadol hydrochloride
Excipient focus: .ALPHA.-TOCOPHEROL
tapentadol hydrochloride drug variants containing .ALPHA.-TOCOPHEROL
tapentadol hydrochloride drug variants not containing .ALPHA.-TOCOPHEROL
Excipient focus: ALUMINUM OXIDE
tapentadol hydrochloride drug variants containing ALUMINUM OXIDE
tapentadol hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
tapentadol hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
tapentadol hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
tapentadol hydrochloride drug variants containing CROSCARMELLOSE SODIUM
tapentadol hydrochloride drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: FD&C BLUE NO. 2
tapentadol hydrochloride drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC | tapentadol hydrochloride | 55700-555 |
| >Company | >Ingredient | >NDC |
tapentadol hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FERROSOFERRIC OXIDE
tapentadol hydrochloride drug variants containing FERROSOFERRIC OXIDE
tapentadol hydrochloride drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: HYPROMELLOSE
tapentadol hydrochloride drug variants containing HYPROMELLOSE
tapentadol hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: LACTOSE MONOHYDRATE
tapentadol hydrochloride drug variants containing LACTOSE MONOHYDRATE
tapentadol hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
tapentadol hydrochloride drug variants containing MAGNESIUM STEARATE
tapentadol hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: POLYETHYLENE GLYCOL
tapentadol hydrochloride drug variants containing POLYETHYLENE GLYCOL
tapentadol hydrochloride drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
tapentadol hydrochloride drug variants containing POLYVINYL ALCOHOL
tapentadol hydrochloride drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
tapentadol hydrochloride drug variants containing POVIDONE
tapentadol hydrochloride drug variants not containing POVIDONE
Excipient focus: PROPYLENE GLYCOL
tapentadol hydrochloride drug variants containing PROPYLENE GLYCOL
tapentadol hydrochloride drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
tapentadol hydrochloride drug variants containing SHELLAC
tapentadol hydrochloride drug variants not containing SHELLAC
Excipient focus: TALC
tapentadol hydrochloride drug variants containing TALC
tapentadol hydrochloride drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
tapentadol hydrochloride drug variants containing TITANIUM DIOXIDE
tapentadol hydrochloride drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
